Techedge Inc. (OTCBB: TEDG) (fka TEDG)

[sweet crude]

TEDG DD info

- Acquiring one of China's biggest flu vaccine producer
- Did $10 mill in sales last year
- Did $1.5 mill in profit
- Has a flu vaccine already in the market
- Doing research on H5N1
- New CEO has 'real' background in flu vaccines
- TEDG not hyped and still cheap
- 82 mill outstanding
- Short term price target = $1.20


VALUATION RATING

Reflecting the size of TianYuan Bio-pharmaceutical research facilities and extensive background in vaccine research, and their stated revenues of $10 million for fiscal 2005, we feel it to be 'fair' to give TEDG a target market cap value of $100 million as compared to other bird flu vaccine producers trading today. TEDG currently has 82 million shares issued and outstanding, which would give TEDG a short-term valuation price target of around $1.20 a share.

http://www.theasianinvestor.com/reports/tedg.htm